Atlas Trials

Ye Xu

2 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Ye Xu

RecordFirmDate
FOLFOX Chemotherapy Combined With Fruquintinib and Serplulimab as First-Line Conversion Therapy for Initially Unresectable pMMR/MSS Colorectal Cancer (NCT07446465)Ye Xu2026-03-01
Alternating Systemic and Hepatic Artery Infusion Therapy As Adjuvant Treatment After Resection of Liver Metastases From Colorectal Cancer (NCT02529774)Ye Xu2015-09-01

Track Ye Xu automatically

Every clearance here is in the API, with alerts when new ones post.